At the end of 2019, a highly contagious infection began its ominous conquest of the world. It
was soon discovered that the disease was caused by a novel coronavirus designated as …

Since the initial identification of the novel coronavirus SARS-CoV-2 in December 2019, the
COVID-19 pandemic has become a leading cause of morbidity and mortality worldwide. As …

SARS-Cov-2 virus has attracted a lot of attention globally, due to the autoimmune and
inflammatory processes that were observed during the development of Covid-19 disease …

The presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been
recently demonstrated in the sputum or saliva, suggesting how the shedding of viral RNA …

To reduce the spread of the severe acute respiratory syndrome coronavirus 2, many
pulmonary function testing (PFT) laboratories have been closed or have significantly …

Patients with preexisting interstitial lung disease (ILD) may be at high risk for severe
coronavirus disease (COVID-19) because of impaired lung function, propensity to develop …

There have been substantial advances in computed tomography (CT) technology since its
introduction in the 1970s. More recently, these advances have focused on image …

Abstract On March 11, 2020, the World Health Organization declared Coronavirus Disease
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …

Idiopathic pulmonary fibrosis (IPF) is considered the paradigmatic example of chronic
progressive fibrosing disease; IPF does not result from a primary immunopathogenic …

Background Patients with interstitial lung disease (ILD) require regular physician visits and
referral to specialist ILD clinics. Difficulties or delays in accessing care can limit opportunities …